Skip to main content
Equibles
AMGN logo

AMGN · Amgen Inc · Analyst Estimates

Track AMGN — free

Use AMGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AMGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$444.63 +5.37 (+1.22%) At close · Oct 26
S&P 500 member Nasdaq-100 member Russell 1000 member Dow 30 member Rebalance outlook locked
Market Cap
$240.38B
Shares
540.63M
Volume · Oct 26 2.13M Avg daily vol (3M) 2.81M

Analyst Estimates

Compare analyst forecasts for Amgen Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-26 13:39 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
22.49
23.03
23.44
33
23.02
23.06
23.04
22.33
3
3
2
3
Revenue
USD
Publication date not stated
38.40B
38.97B
39.46B
31
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
22.88
24.49
26.37
31
24.50
24.45
24.40
23.45
1
1
4
7
Revenue
USD
Publication date not stated
38.80B
40.38B
44.05B
29
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
5.47
5.79
6.09
28
5.76
5.78
5.78
5.74
3
3
2
2
Revenue
USD
Publication date not stated
9.85B
10.08B
10.28B
25
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
5.19
5.77
6.10
26
5.78
5.80
5.80
5.77
1
1
4
4
Revenue
USD
Publication date not stated
9.89B
10.28B
10.54B
23
 — — — — — — — —
Key facts CIK 318154 CUSIP 031162100 13F (30d) 1093 filings 1068 filers Visit website Investor relations